 NEW YORK, Oct. 18, 2021 GLOBE NEWSWIRE -- Fortress Biotech, Inc. NASDAQ: FBIO Fortress, an innovative biopharmaceutical company focused on acquiring, developing and commercializing or monetizing promising biopharmaceutical products and product candidates cost-effectively, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will present a corporate update at Dawson James Securities 6th Annual Small Cap Growth Conference on Thursday, October 21, 2021, at 1:10 p.m. ET and will participate in one-on-one meetings during the conference. 